WASHINGTON (AP) — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, maker Gilead Sciences announced ...

Clinical trials showed 99.9% of participants who received the drug, called Yeztugo​ from company Gilead Sciences, remained ...

The Southeastern Conference revealed the Longhorns' opponents and sites for the upcoming 16-game conference schedule, and the ...

A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...

The drug could change the course of the AIDS epidemic. But the Trump administration has gutted the programs that might have ...

(Reuters) -The U.S. Food and Drug Administration on Wednesday approved Gilead Sciences' lenacapavir, a twice-yearly injection ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

Cam Smith doesn’t always hit home runs. But when he does, they tend to come in bunches. The rookie outfielder went yard twice ...

Cam Smith doesn’t always hit home runs. But when he does, they tend to come in bunches. The rookie outfielder went yard twice ...

Make it two titles in a row for Tkachuk, Barkov & Co., who are as gracious off the ice as they are mean on it.